Comprehensive resources and coverage so you and your patients can focus on treatment

Administering Euflexxa

Watch how you can help deliver the full benefit of EUFLEXXA with 3 injections over 3 weeks.
Injection Instructions

Office Materials

Here are some helpful resources to assist you and your patients in understanding what to expect from EUFLEXXA.
Want these resources on-hand in your office?
Order now
Patient
Brochure
Post-injection
Instructions

Dual-Acting Effects

Find out how EUFLEXXA may help your patients’ OA knee pain in two ways.

Discover the Effects

Get Euflexxa

See how getting treatment for your
patients can be easy convenient.

Learn More

Access

Most commercially insured patients can get EUFLEXXA under their medical benefits.

Preferred formulary status by many of the largest commercial plans with
fewer access restrictions*

EUFLEXXA is covered under the pharmacy benefit by many insurers such as UnitedHealthcare, OptumRx, Express Scripts, and the Veterans Administration.

*Subject to change based on individual plan coverage. Check the member’s benefits for more details.

~50% of Commercially Insured Patients Pay A
on Medicare Part B
without restrictions

*Subject to change based on individual plan coverage. Check the member’s benefits for more details.

Practices that utilized the hub for their initial benefits investigation saw 99% of their claims approved2
Enroll Today

Euflexxa Solution Center

A hub that streamlines everything from insurance verification to patient support

Helps you and your staff navigate the coverage landscape¶# with comprehensive programs that

connect patients with support

Benefits investigations are completed within 24 hours while you track progress online

For Solution Center questions call 1-866-383-5391 or fax 1-866-383-5392.

Patient Direct Program

A program that provides access for patients who are underinsured or uninsured.

Available to a wide range of patients.

See eligibility criteria

Quick and easy to enroll via fax or through the

EUFLEXXA Solution Center

Managed by CareMed

Euflexxa Commitment

If your patient is not satisfied with their OA knee pain relief 10 weeks after their last EUFLEXXA injection, we offer up to a $100 refund for copay costs. The patient must have received 1 EUFLEXXA injection a week for 3 weeks between the eligibility period.

Offer Terms and Conditions apply

To receive the refund, we need the following information no later than 14 weeks after the patient’s last injection to process their refund:

  1. Completed refund form
  2. Explanation of Benefits for each injection from the insurance company
  3. Receipts for their EUFLEXXA copay payment
  4. Fax the documents to 1-866-383-5392

†Preferred access refers to favorable formulary status, medical policy, or fewer restrictions for EUFLEXXA.

‡Allowed for buy and bill.

§BCBS IL, BCBS MT, BCBS NM, BCBS OK, and BCBS TX.

The Solution Center will respond to each fax submission within 24 hours, notifying you of a patient’s coverage via the Benefits Investigation Report.

#The EUFLEXXA Solution Center does not file claims or appeal claims, and cannot guarantee that you will be successful in obtaining reimbursement. Third-party payment for medical products and services is affected by numerous factors, none of which can be anticipated or resolved by the Solution Center.

Dual-Acting Effects

Find out how EUFLEXXA may help your patients’ OA knee pain in two ways.

Discover the Effects

Get Euflexxa

See how getting treatment for your
patients can be easy convenient.

Learn More
  1. Rolling 12 month average of IQVIA claims data based on unique patients (December 2022).
  2. Data on file. Ferring Pharmaceuticals Inc. (December 2022).

Please see Important Safety Information and Full Prescribing Information

Indication

EUFLEXXA (1% sodium hyaluronate) is used to relieve knee pain due to osteoarthritis. It is used for patients who do not get enough relief from simple pain medications such as acetaminophen or from exercise and physical therapy.

EUFLEXXA is only for injection into the knee, performed by a doctor or other qualified healthcare professional.

Important Safety Information

  • Do not take this product if you have had any previous allergic reaction to EUFLEXXA or hyaluronan products.
  • You should not have EUFLEXXA injected into the knee if you have a knee joint infection or skin diseases or infections around the injection site.
  • EUFLEXXA has not been tested in pregnant women, women who are nursing or in children less than 18 years of age. After you receive your EUFLEXXA injection you should avoid physical activities for 48 hours such as jogging, tennis, heavy lifting, or standing on your feet for a long time (more than one hour at a time.)
  • The most common adverse events related to EUFLEXXA injections were joint pain, back pain, limb pain, muscle pain, and joint swelling.

Please see full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

You may also contact Ferring Pharmaceuticals Inc. at 1-888-FERRING.

Indication

EUFLEXXA (1% sodium hyaluronate) is used to relieve knee pain due to osteoarthritis. It is used for patients who do not get enough relief from simple pain medications such as acetaminophen or from exercise and physical therapy.

EUFLEXXA is only for injection into the knee, performed by a doctor or other qualified healthcare professional.

Important Safety Information

  • Do not take this product if you have had any previous allergic reaction to EUFLEXXA or hyaluronan products.
  • You should not have EUFLEXXA injected into the knee if you have a knee joint infection or skin diseases or infections around the injection site.
  • EUFLEXXA has not been tested in pregnant women, women who are nursing or in children less than 18 years of age. After you receive your EUFLEXXA injection you should avoid physical activities for 48 hours such as jogging, tennis, heavy lifting, or standing on your feet for a long time (more than one hour at a time.)
  • The most common adverse events related to EUFLEXXA injections were joint pain, back pain, limb pain, muscle pain, and joint swelling.

Please see full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

You may also contact Ferring Pharmaceuticals Inc. at 1-888-FERRING.

 

The content on this website is for informational purposes only and is not intended to replace a discussion with a healthcare professional.

The EUFLEXXA Commitment Program Offer
Terms & Conditions:

  • This offer is not valid for any other Ferring Pharmaceuticals Inc product. Fax-in only. No mail, phone, or emailed requests will be honored
  • Ferring Pharmaceuticals is not responsible for lost, late, damaged, misdirected, incomplete or illegible submissions
  • The value of this refund may not exceed the amount of patient’s responsibility (copay) for the prescription. Maximum refund amount is $100
  • Offer limited to cash-paying or commercial US residents who received three (3) injections of EUFLEXXA within 21 days as indicated (ie, one injection a week for 3 weeks and are undergoing their first EUFLEXXA treatment regimen)
  • Refund claims must be received between 10 and 14 weeks after the last injection
  • Limit one refund per eligible patient
  • Ferring Pharmaceuticals reserves the right to cancel, modify, or rescind the program at any time
  • The patient responsibility (copay) for the injection administration and/or EUFLEXXA must be isolated on the claim. Office visits or other ancillary costs included in patient’s responsibility are excluded from refund amount
  • This offer is void where prohibited or restricted by law. Offer not valid for prescriptions and/or services reimbursed in whole or in part by any federal or state healthcare program, including without limitation Medicare, Medicaid, Department of Veterans Affairs healthcare program, TRICARE, and any federal or state employee benefit program
  • Please retain copies of the materials you submit. All submissions become the property of a Ferring Pharmaceuticals contracted third-party vendor
  • Patient must fully complete and follow instructions as stated on the claim form
  • Tampering with, altering, or falsifying payment information constitutes fraud
  • Please allow 4-6 weeks for delivery of refund check. Refund check will be issued in US dollars

Get a head start: Check your coverage and sign up for your EUFLEXXA coverage certificate

Check your coverage below to see if you may be covered through your insurance provider for EUFLEXXA

EUFLEXXA is covered on Medicare Part B*, and is covered by most private plans. Your healthcare provider’s office will check your benefits.

Your EUFLEXXA coverage certificate will let you know if you are covered. Bring your certificate to your doctor to discuss EUFLEXXA as a possible treatment option for you.

MM slash DD slash YYYY
Address(Required)

By signing up, I am giving Ferring Pharmaceuticals Inc. (“Ferring”) permission to store and use the information that I have provided. I understand and agree that my information will be used by Ferring (or companies working on Ferring’s behalf) to contact me by telephone, email, or mail to provide me with information about products or services that may be of interest to me. I understand that my information will be treated as described in Ferring’s Privacy Notice, which provides details about my privacy rights. Also, I understand that I may opt out of the database at any time by making the request at Data Subject Form, or by calling 1-888-FERRING, Monday through Friday, 8 AM to 7 PM ET to speak to a representative or leave a voicemail. This statement may be updated from time to time.

This program assists in the determination of whether treatment could be covered by the applicable third-party payer based on coverage guidelines provided by the payer and patient information provided by you. Third-party reimbursement is affected by many factors. Therefore, we make no representation or guarantee that full or partial insurance reimbursement or any other payment will be available. This is not intended to be medical advice. Please consult with your healthcare provider to determine which treatment may be right for you.

*Out-of-pocket cost may apply. Please check with your doctor.

Injection Techniques

This website may contain links to, or be accessed from links on, other worldwide websites. Ferring does not have responsibility for or control the contents, availability, operation or performance of other websites to which this website may be linked or from which this website may be accessed.

Ferring makes no representation regarding the content of any other websites which you may access from this website.

Ok Cancel